Ticker > Company >

Poly Medicure share price

Poly Medicure Ltd.

NSE: POLYMED BSE: 531768 SECTOR: Medical Equipment/Supplies/Accessories  1.33 L   576   79

1985.80
+28.75 (1.47%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 2070.55

Today's Low

₹ 1945.05

52 Week High

₹ 3350

52 Week Low

₹ 1822.65

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

20121.26 Cr.

Enterprise Value

20147.93 Cr.

No. of Shares

10.13 Cr.

P/E

57.99

P/B

7.11

Face Value

₹ 5

Div. Yield

0.18 %

Book Value (TTM)

₹  279.28

CASH

143.19 Cr.

DEBT

169.86 Cr.

Promoter Holding

62.44 %

EPS (TTM)

₹  34.24

Sales Growth

22.53%

ROE

15.79 %

ROCE

20.14%

Profit Growth

31.63 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year22.53%
3 Year22.13%
5 Year19.91%

Profit Growth

1 Year31.63%
3 Year31.41%
5 Year29.1%

ROE%

1 Year15.79%
3 Year16.68%
5 Year16.64%

ROCE %

1 Year20.14%
3 Year20.92%
5 Year20.41%

Debt/Equity

0.0619

Price to Cash Flow

85.03

Interest Cover Ratio

33.7968

CFO/PAT (5 Yr. Avg.)

0.898424835943701

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 62.44 0.00
Mar 2025 62.44 0.00
Dec 2024 62.44 0.00
Sep 2024 62.56 0.00
Jun 2024 66.03 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 31.4077766749921% for the Past 3 years.
  • The company has shown a good revenue growth of 22.127472653182% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 20.9189666666667% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 33.7968.
  • The Company has been maintaining an effective average operating margins of 26.3204055130091% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 46.8866 days.
  • Company has a healthy liquidity position with current ratio of 4.5361.
  • The company has a high promoter holding of 62.44%.

 Limitations

  • The company is trading at a high PE of 57.99.
  • The company is trading at a high EV/EBITDA of 35.9636.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 367.43 402.47 410.94 420.97 384.05
Total Expenditure 266.35 289.54 295.34 304.93 282.42
Operating Profit 101.08 112.93 115.6 116.04 101.63
Other Income 16.83 27.24 21.75 23.95 41.1
Interest 2.98 3.13 3.13 2.17 2.81
Depreciation 18.85 20.11 20.83 21.33 22.84
Exceptional Items 0 0 0 0 0
Profit Before Tax 96.08 116.93 113.39 116.5 117.06
Tax 23.77 29.71 28.24 29.84 29.14
Profit After Tax 72.3 87.22 85.15 86.66 87.93
Adjusted EPS (Rs) 7.53 8.61 8.4 8.55 8.68

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 747.38 879.36 1068.05 1307.25 1601.8
Total Expenditure 537.03 665.47 801.67 956.11 1154.34
Operating Profit 210.36 213.89 266.37 351.14 447.46
Other Income 19.29 38.73 36.29 58.18 89.77
Interest 9.95 5.36 10.19 12.85 13.5
Depreciation 46.31 52.54 55.64 61.57 80.84
Exceptional Items 0 0 0 0 0
Profit Before Tax 173.38 194.72 236.83 334.89 442.89
Tax 43.87 48.7 57.78 83.17 111.56
Net Profit 129.51 146.02 179.04 251.72 331.33
Adjusted EPS (Rs.) 13.51 15.23 18.66 26.23 32.7

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 47.94 47.95 47.97 47.99 50.66
Total Reserves 906.07 1029.02 1186.15 1410.26 2693.56
Borrowings 59.74 30.56 11.56 0.84 0
Other N/C liabilities 21.67 23.15 23.13 34.75 54.34
Current liabilities 195.54 203.27 326.81 400.32 429.44
Total Liabilities 1230.96 1333.96 1595.63 1894.16 3228
Assets
Net Block 384.97 447.46 597.43 830.82 1047.35
Capital WIP 14.74 37.11 72.53 66.67 89.47
Intangible WIP 6.43 5.86 5.21 4.04 3.32
Investments 39.8 46.94 56.96 81.07 70.66
Loans & Advances 12.73 31.85 41.89 38.63 55.5
Other N/C Assets 55.06 23.75 8.49 8.33 13.73
Current Assets 717.23 740.99 813.13 864.59 1947.98
Total Assets 1230.96 1333.96 1595.63 1894.16 3228
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 173.38 194.72 236.83 334.89 442.89
Adjustment 44.94 38.6 60.17 35.82 36.36
Changes in Assets & Liabilities -57.79 -60.19 -42.33 -40.87 -153.59
Tax Paid -44.14 -46.86 -57.84 -73.74 -89.01
Operating Cash Flow 116.4 126.26 196.83 256.1 236.65
Investing Cash Flow -434.41 -88.71 -189.18 -237.02 -1191.17
Financing Cash Flow 318.92 -39.71 -7.89 -17.32 952.93
Net Cash Flow 0.9 -2.16 -0.25 1.76 -1.59

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 66.03 62.56 62.44 62.44 62.44
aaryaman baid 0.29 0.28 0.28 0.28 0.28
arham baid 0.29 0.28 0.28 0.28 0.28
dhruv baid 0.38 0.36 0.36 0.36 0.36
ezekiel global business s... 12.88 12.20 12.20 12.20 12.20
himanshu baid 8.24 7.81 7.80 7.80 7.80
himanshu baid (huf) - 3.79 3.79 3.79 3.79
jai polypan private limit... - - - - 3.26
jugal kishore baid 2.38 2.25 2.25 2.25 2.25
madhu kothari 0.16 0.15 0.15 0.15 0.15
neha baid 1.07 1.01 1.01 - 1.01
polycure martech limited 0.01 0.01 0.01 0.01 0.01
rishi baid 10.18 9.64 9.59 9.59 9.59
rishi baid (huf) - 2.74 2.74 2.74 2.74
shaily baid 1.24 1.17 1.17 1.17 1.17
shireen baid - - - 1.11 1.11
smt. mukulika baid - 3.02 3.02 3.02 3.02
vcb trading llp 3.69 3.50 3.49 3.49 3.49
vinay kothari 0.06 0.06 0.06 0.06 0.06
vishal baid 1.75 1.66 1.66 1.66 1.66
zetta matrix consulting l... 8.67 8.22 8.21 8.21 8.21
jai polypan pvt. ltd. - 3.31 3.26 3.26 -
neha baid - - - 1.01 -
shireen baid 1.17 1.11 1.11 - -
himanshu baid (huf) 4.00 - - - -
jai polypan pvt. ltd 3.49 - - - -
rishi baid(huf) 2.90 - - - -
smt.mukulika baid 3.19 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 33.97 37.44 37.56 37.56 37.56
axis max life insurance l... - - - 1.94 2.03
lighthouse india fund iv ... - 1.16 1.37 1.37 1.37
nirmala vinodkumar daga 2.12 1.84 1.80 1.80 1.79
quant mutual fund - quant... - - - 3.35 3.52
shreans daga 1.53 1.45 1.43 1.43 1.43
smallcap world fund, inc 2.26 1.79 1.66 1.66 2.02
uti nifty midsmallcap 400... - - - - 1.50
varun daga 1.62 1.54 1.54 1.54 1.54
uti nifty midsmallcap 400... - - - 1.62 -
max life insurance co ltd... - - 1.67 - -
quant mutual fund - quant... - 3.51 3.51 - -
uti - healthcare fund 2.02 1.78 1.66 - -
max life insurance compan... - 1.71 - - -
max life insurance compan... 1.54 - - - -
quant mutual fund - quant... 3.43 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q1FY25
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY25
Presentation Q3FY21
Presentation Q1FY26
Presentation FY2024

Company News

Poly Medicure Stock Price Analysis and Quick Research Report. Is Poly Medicure an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Poly Medicure. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Poly Medicure has a PE ratio of 58.2823967127992 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Poly Medicure has ROA of 12.9373% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Poly Medicure has a Current ratio of 4.5361.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Poly Medicure has a ROE of 15.7899%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Poly Medicure has a Debt to Equity ratio of 0.0619 which means that the company has low proportion of debt in its capital.

  • Sales growth: Poly Medicure has reported revenue growth of 22.5321% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Poly Medicure for the current financial year is 27.934939185284%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Poly Medicure is Rs 3.5 and the yield is 0.175%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Poly Medicure is Rs 34.2419. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Poly Medicure in Ticker for free. Also, one can get the intrinsic value of Poly Medicure by using Valuation Calculators, which are available with a Finology ONE subscription. 

Poly Medicure FAQs

Q1. What is Poly Medicure share price today?
Ans: The current share price of Poly Medicure is Rs 1995.7.

Q2. What is the market capitalisation of Poly Medicure?
Ans: Poly Medicure has a market capitalisation of Rs 20221.57294255 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Poly Medicure?
Ans: The PE ratio of Poly Medicure is 58.2823967127992 and the P/B ratio of Poly Medicure is 7.14577276177654, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Poly Medicure share?
Ans: The 52-week high share price of Poly Medicure is Rs 3357.8, and the 52-week low share price of Poly Medicure is Rs 1821.2.

Q5. Does Poly Medicure pay dividends?
Ans: Currently, Poly Medicure pays dividends. Dividend yield of Poly Medicure is around 0.175%.

Q6. What are the face value and book value of Poly Medicure shares?
Ans: The face value of Poly Medicure shares is Rs 5, while the book value per share of Poly Medicure is around Rs 279.284. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Poly Medicure?
Ans: Poly Medicure has a total debt of Rs 169.8593 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Poly Medicure?
Ans: The ROE of Poly Medicure is 15.7899% and ROCE of Poly Medicure is 20.1381%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Poly Medicure a good buy for the long term?
Ans: The Poly Medicure long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Poly Medicure undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Poly Medicure appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Poly Medicure’s financials?
Ans: You can review Poly Medicure’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Poly Medicure
X